The Effect of Mandala Art Therapy on Anxiety and Pain in Patients Undergoing Total Hip Arthroplasty: A Randomized Controlled Trial.

Pain Manag NursMay 29, 2026 (epub)
Clinical ResearchOrthopedic SurgeryAnesthesiologyPhysical Medicine & Rehabilitation

Seval Ulubay, Hatice Merve Alptekin

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the impact of mandala art therapy on anxiety and pain in 84 patients undergoing total hip arthroplasty. The intervention group experienced significant reductions in anxiety (STAI-I score: 41.43 ± 3.72) and pain (VAS score: 4.62 ± 1.08) after therapy, with p-values indicating strong statistical significance (p < .001).

Key findings

  • Mandala art therapy significantly reduced anxiety levels (B = -1.641; p = .031).
  • Pain levels decreased significantly after mandala art therapy (B = -0.857; p < .001).
  • The intervention was conducted on the second postoperative day.
  • No significant differences were noted between groups at baseline (p > .05).

Why it matters

The findings suggest that incorporating mandala art therapy into postoperative care can enhance patient comfort by alleviating anxiety and pain, potentially improving recovery outcomes after total hip arthroplasty.

Source

PubMed · PMID 42215343

Published in Pain Manag Nurs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Orthopedic Surgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.